Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-02-04 16:17:49
Reporting Period:
Accepted Time:
2019-02-04 16:17:49
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194413 J Larry Merlo One Cvs Drive
Woonsocket RI 02895-
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-01 166,368 $45.07 496,577 No 4 M Direct
Common Stock Disposition 2019-02-01 166,368 $64.51 330,209 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-02-01 166,368 $0.00 166,368 $45.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-04-02 2019-04-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 378,463 Indirect By Trust As Beneficiary
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $62.91 and $65.29 per share.
  3. Option became exercisable in four equal annual installments, commencing 4/2/2013.